TP63-TRIM29 axis regulate enhancer methylation and chromosomal instability in prostate cancer
Султанов Ринат ИлгизовичiD, A. MulyukinaiD, Olga A. ZubkovaiD, A. Fedoseeva, Alexandra N. BogomazovaiD, Ksenia M. KliminaiD, Andrey K. LariniD, Timofei S. ZatsepiniD, T. A. Prikazchikova, Maria M. LukinaiD, Margarita E. BogomiakovaiD, Elena Ivanovna SharovaiD, Edward V. GenerozoviD, Maria A. LagarkovaiD, Georgij P. ArapidiiD
Abstract
AO_SCPLOWBSTRACTC_SCPLOWProstate adenocarcinoma (PRAD) is the second most common cause of cancer-related deaths in men. PRAD is often characterized by DNA methylation variability and a high rate of large genomic rearrangements. To elucidate the reasons behind such high variance, we used weighted gene co-expression network analysis for integration RNA-seq, DNA methylation and copy number alterations data from The Cancer Genome Atlas PRAD. Our results show that only a single cluster of co-expressed genes is associated with genomic and epigenomic instability. Within this cluster, TP63 and TRIM29 are key transcription regulators. We revealed that TP63 regulates the level of enhancer methylation in prostate basal epithelium cells. TRIM29 forms a complex with TP63 and together regulate the expression of genes specific to the prostate basal epithelium. Moreover, TRIM29 binds DNA repair proteins and prevents formation of the TMPRSS2:ERG gene fusion typically observed in PRAD. Therefore, the study shows that TRIM29 and TP63 are important regulators maintaining the identity of the basal epithelium under physiological conditions. Finally, we uncover the role of TRIM29 in PRAD development.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 2.89
- Field percentile
- top 9%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming
F. Li, Q. Yuan, … D. Gao·Journal of Clinical InvestigationPeer-reviewed·Oct 5, 2020
- Exploration of oncogenic cooperation between germline variation and somatic mutation in prostate cancer progression
Zuzanna Kolodynska, Kimberley M. Hanssen, … Thomas G. P. Grünewald·bioRxiv·Aug 5, 2025
- Transcriptional elongation machinery controls vulnerability of breast cancer cells to PRC2 inhibitors
W. Xu, N. T. Chan, … L. Li·bioRxiv·Jan 8, 2020
- A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator that promotes prostate cancer proliferation.
Raymond J. Kostlan, John T. Phoenix, … Steven Kregel·bioRxiv·Jul 9, 2026
- BAZ2A association with H3K14ac is required for the transition of prostate cancer cells into a cancer stem-like state
Rodrigo Peña‐Hernández, Rossana Aprigliano, … Raffaella Santoro·EMBO ReportsPeer-reviewed·Aug 17, 2021
- Extensive germline-somatic interplay drives prostate cancer through HNF1B co-option of TMPRSS2-ERG
N. Giannareas, Q. Zhang, … G.-H. Wei·bioRxiv·Sep 2, 2021